Post-translational modifications in bladder cancer: Expanding the tumor target repertoire.

@article{Oo2018PosttranslationalMI,
  title={Post-translational modifications in bladder cancer: Expanding the tumor target repertoire.},
  author={Htoo Zarni Oo and Roland Seiler and Peter C. Black and Mads Daugaard},
  journal={Urologic oncology},
  year={2018}
}
Unconventional protein post-translational modifications: the helmsmen in breast cancer
Breast cancer is the most prevalent malignant tumor and a leading cause of mortality among females worldwide. The tumorigenesis and progression of breast cancer involve complex pathophysiological
Post-Translational Modifications That Drive Prostate Cancer Progression
TLDR
A comprehensive list of proteome-wide and single protein post-translational modifications and their involvement in phenotypic outcomes is presented and current strategies that exploit the potential of post- Translated modifications in prostate cancer therapy are presented.
SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer
TLDR
The complicated regulation mechanisms of SUMOylation in bladder cancer could be helpful in guiding clinical therapeutic strategy and improving the prognosis of patients with BCa.
Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer
TLDR
It is reported that elevated oncofetal CS expression predicts poor disease-free and overall survival in four independent patient cohorts of early-stage NSCLC, independent of KRAS and EGFR mutations, and preclinical proof that onco Fetal CS is an actionable prognosticator and therapeutic receptor in wild-type and KRAS-mutatedNSCLC is provided.
PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target
TLDR
It is shown that PIAS1 has no influence on reducing the cytotoxic effects of Cisplatin or cell recovery after DNA damage induced by irradiation, and is not a promising therapeutic target in UC cancer.
USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target
TLDR
This review will give a comprehensive introduction of USP4 about its regulatory mechanisms, related signaling pathways, pathophysiological functions and the roles in various cancers which may help to better understand its biological functions and improve future studies to construct suitable USP 4-targeted cancer therapy system.
The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells
TLDR
Examination of the expression of ADAM panel in the clinical specimens of bladder cancer found that overexpression of miR-3174 in bladder cancer cells inhibited the proliferation of cells due to the inhibition ofADAM15.
Differences of the tumour cell glycocalyx affect binding of capsaicin-loaded chitosan nanocapsules
TLDR
Exome sequencing data of cancer patients and analysis of distinct melanoma and bladder cancer cell lines suggest differences in cancer cell-exposed glycocalyx components affected the binding of cationic chitosan nanocapsules (Chi-NCs), indicating that the glycocalyX of tumour cells controls the binding and biological activity of nanoparticles.
DeepSSPred: A Deep Learning Based Sulfenylation site predictor via a novel n-segmented optimize federated feature encoder.
  • Z. Khan, D. Pi
  • Computer Science
    Protein and peptide letters
  • 2020
TLDR
This research has developed a novel sequence-based automated predictor for SC-sites, called DeepSSPred, and empirical analyses show the superlative performance of the proposed model over both training and Independent dataset in comparison with existing literature studies.
...
1
2
...

References

SHOWING 1-10 OF 111 REFERENCES
Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension
TLDR
STn overexpression may, in part, result from a HIF-1α mediated cell-survival strategy to adapt to the hypoxic challenge, favouring cell invasion and targeting STn-expressing glycoproteins may offer potential to treat tumour hypoxic niches harbouring more malignant cells.
Post-translational modifications of the extracellular matrix are key events in cancer progression: Opportunities for biochemical marker development
TLDR
The importance of remodeling of the ECM in cancer and the generation of PTMs, which may be cancer specific and reflect disease progression, are highlighted, thus having potential for biochemical marker development.
Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics
TLDR
STn was found to be marker of poor prognosis in bladder cancer and, in combination with PI3K/Akt/mTOR pathway evaluation, holds potential to improve the stratification of stage disease.
Alterations of histone H1 phosphorylation during bladder carcinogenesis.
TLDR
Profiling the histone modifications during the progression of bladder cancer revealed a statistically significant increase in phosphorylation of H1 linker histones from normal human bladder epithelial cells to low-grade superficial to high-grade invasive bladder cancer cells.
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.
TLDR
A review and perspective on important post-translational modifications on non-histone proteins, with emphasis on their roles in diseases and small molecule inhibitors developed to target PTM writers are presented.
Quantitative analysis of protein-protein interactions and post-translational modifications in rare immune populations
TLDR
It is demonstrated that PLIC overcomes the inherent limitations of conventional proteomic approaches and enables a high-resolution detection and quantification of PPIs and PTMs at a single cell level.
Ras-MAPK pathway as a therapeutic target in cancer--emphasis on bladder cancer.
TLDR
The importance of the Ras-MAPK pathway in cancer is summarized with a focus on bladder cancer and current drugs and recent patents that target this important pathway in bladder cancer are discussed.
Does phosphorylation of cofilin affect the progression of human bladder cancer?
TLDR
The results demonstrate that the increased expression and phosphorylation of cofilin might play a role in the occurrence and invasiveness of bladder cancer.
Glycosylation defining cancer malignancy: New wine in an old bottle
  • S. Hakomori
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2002
TLDR
The concept of glycosylation-dependent promotion or inhibition of tumor progression has developed in conjunction with clinicopathological studies and appears to be considered “in the shade” of more popular topics such as oncogenes and antioncogene, apoptosis, angiogenesis, growth factor receptors, integrin and caderin function, etc., despite the fact that aberrant glycosYLation profoundly affects all of these processes.
...
1
2
3
4
5
...